Medtronic’s Drug-Coated Balloon Impresses In Peripheral Artery Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Medtronic may have gained an edge over C.R. Bard in the future U.S. drug-coated balloon market as one-year results of a randomized trial of its IN.PACT Admiral paclitaxel-coated peripheral angioplasty balloon appear to be the best yet for a peripheral intervention device.